BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ständer S, Raap U, Weisshaar E, Schmelz M, Mettang T, Handwerker H, Luger TA. Pathogenesis of pruritus. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2011;9:456-63. [DOI: 10.1111/j.1610-0387.2011.07585.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Hwang JS, Kim G, Park E, Kim J, Chae C, Hwang W, Lee C, Hwang S, Wang HS, Jun C, Rudra D, Im S. NFAT1 and JunB Cooperatively Regulate IL-31 Gene Expression in CD4 + T Cells in Health and Disease. J I 2015;194:1963-74. [DOI: 10.4049/jimmunol.1401862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 Esmaeili A, Baharvand P, Sahebi L, Esmaeili A, Nassiri Toosi M, Namazi S. Validity and Reliability of Persian Version of 12-Item Pruritus Severity Score Questionnaire in Patients with Chronic Liver Disease and Pruritus. Middle East J Dig Dis 2020;12:278-83. [PMID: 33564386 DOI: 10.34172/mejdd.2020.194] [Reference Citation Analysis]
3 Ruppenstein A, Limberg MM, Loser K, Kremer AE, Homey B, Raap U. Involvement of Neuro-Immune Interactions in Pruritus With Special Focus on Receptor Expressions. Front Med (Lausanne) 2021;8:627985. [PMID: 33681256 DOI: 10.3389/fmed.2021.627985] [Reference Citation Analysis]
4 Elmariah SB, Lerner EA. Topical therapies for pruritus. Semin Cutan Med Surg 2011;30:118-26. [PMID: 21767774 DOI: 10.1016/j.sder.2011.04.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
5 Mavrogiorgou P, Juckel G. [Dermatological diseases and their importance for psychiatry]. Nervenarzt 2017;88:254-67. [PMID: 26975652 DOI: 10.1007/s00115-016-0082-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Frech T, Novak K, Revelo MP, Murtaugh M, Markewitz B, Hatton N, Scholand MB, Frech E, Markewitz D, Sawitzke AD. Low-dose naltrexone for pruritus in systemic sclerosis. Int J Rheumatol 2011;2011:804296. [PMID: 21918649 DOI: 10.1155/2011/804296] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
7 Mitsuishi T, Tominaga M, Miyata K, Toyama S, Kimura U, Suga Y, Takamori K. Excimer light therapy with systemic corticosteroids improved severe chronic nodular prurigo and altered peripheral nerve fibers in the epidermis. Lasers Med Sci 2022. [PMID: 35508565 DOI: 10.1007/s10103-022-03570-8] [Reference Citation Analysis]
8 Obara I, Medrano MC, Signoret-Genest J, Jiménez-Díaz L, Géranton SM, Hunt SP. Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice. Pain 2015;156:1519-29. [PMID: 25906350 DOI: 10.1097/j.pain.0000000000000197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
9 Bin Saif GA, Ericson ME, Yosipovitch G. The itchy scalp--scratching for an explanation. Exp Dermatol 2011;20:959-68. [PMID: 22092575 DOI: 10.1111/j.1600-0625.2011.01389.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
10 Alam M, Buddenkotte J, Ahmad F, Steinhoff M. Neurokinin 1 Receptor Antagonists for Pruritus. Drugs 2021;81:621-34. [PMID: 33675531 DOI: 10.1007/s40265-021-01478-1] [Reference Citation Analysis]
11 Wilson SR, Nelson AM, Batia L, Morita T, Estandian D, Owens DM, Lumpkin EA, Bautista DM. The ion channel TRPA1 is required for chronic itch. J Neurosci 2013;33:9283-94. [PMID: 23719797 DOI: 10.1523/JNEUROSCI.5318-12.2013] [Cited by in Crossref: 127] [Cited by in F6Publishing: 76] [Article Influence: 14.1] [Reference Citation Analysis]
12 Baraniuk JN. Rise of the sensors: nociception and pruritus. Curr Allergy Asthma Rep 2012;12:104-14. [PMID: 22367178 DOI: 10.1007/s11882-012-0245-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 Nilius B, Szallasi A, Sibley DR. Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine. Pharmacol Rev 2014;66:676-814. [DOI: 10.1124/pr.113.008268] [Cited by in Crossref: 291] [Cited by in F6Publishing: 274] [Article Influence: 36.4] [Reference Citation Analysis]
14 Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF. Non-allergic, mastocytosis-associated rhinitis. Clin Exp Allergy 2013;43:406-12. [DOI: 10.1111/cea.12053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
15 Savage WJ, Savage JH, Tobian AA, Thoburn C, Hamilton RG, Schroeder JT, Ness PM. Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion 2012;52:575-81. [PMID: 21883267 DOI: 10.1111/j.1537-2995.2011.03310.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
16 Xiao L, Qiu W, Lu Z, Li R, Hu X. Intractable pruritus in neuromyelitis optica. Neurol Sci 2016;37:949-54. [DOI: 10.1007/s10072-016-2523-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]